Korean Drug Co., Ltd. (KOSDAQ: A014570)
Health Care · Pharmaceuticals · KR
₩3,190.00
-2.60% today · -27.6% 1Y
Korean Drug Co., Ltd. (KOSDAQ: A014570) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $25.89M.
Over the last twelve months the share price has lost 27.6%, trading between 3.06K and 4.55K.
Tweenvest scores Korean Drug Co., Ltd. across four factors: quality 73/100, value 74/100, growth 4/100. Its strongest factor is value.
A014570 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.89M
- Revenue (TTM)
- $42.22M
- P/E
- 23.30
- EPS
- 136.90
- Dividend yield
- —
- Beta (5Y)
- 0.23
- 52-week high
- ₩4,550.00
- 52-week low
- ₩3,060.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.91M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Korea Arlico Pharm Co.,Ltd.KOSDAQ: A260660 | $26.68M | ₩2,340.00 | +3.54% |
| Winston Medical Supply Co., Ltd.TPEX: 6817 | $26.38M | NT$45.80 | -2.86% |
| Cessatech A/SNGM: CESSA | $26.25M | Dkr9.30 | +1.75% |
| Earth Science Tech, Inc.OTCPK: ETST | $26.23M | $0.09 | +0.11% |
| Neimeth International Pharmaceuticals PlcNGSE: NEIMETH | $25.71M | ₦7.00 | -6.04% |
| MariMed Inc.OTCPK: MRMD | $25.53M | $0.06 | -8.19% |
| IRLAB Therapeutics AB (publ)OM: IRLAB A | $25.37M | Skr1.71 | -8.08% |
| Cilo Cybin Holdings LimitedJSE: CCC | $25.26M | R1.45 | -2.68% |
Figures last refreshed Oct 11, 2026.